

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 8.27975019 |
| 2 | negative thymic T cell selection (GO:0045060) | 8.14754497 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.83344165 |
| 4 | positive thymic T cell selection (GO:0045059) | 7.60820043 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.54186027 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.54186027 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.06138042 |
| 8 | negative regulation of cell killing (GO:0031342) | 7.06138042 |
| 9 | thymic T cell selection (GO:0045061) | 6.98160867 |
| 10 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.87639274 |
| 11 | positive T cell selection (GO:0043368) | 6.82991196 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.67955873 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.56359730 |
| 14 | response to interleukin-15 (GO:0070672) | 6.41911963 |
| 15 | interferon-gamma production (GO:0032609) | 6.36723738 |
| 16 | cellular response to interleukin-15 (GO:0071350) | 6.34038707 |
| 17 | T cell selection (GO:0045058) | 6.29791078 |
| 18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.17253996 |
| 19 | T cell migration (GO:0072678) | 6.01328767 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 5.91189977 |
| 21 | leukocyte aggregation (GO:0070486) | 5.79394331 |
| 22 | regulation of T cell tolerance induction (GO:0002664) | 5.65175692 |
| 23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.50838169 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.39403884 |
| 25 | T cell costimulation (GO:0031295) | 5.30099818 |
| 26 | T cell receptor signaling pathway (GO:0050852) | 5.28298810 |
| 27 | lymphocyte costimulation (GO:0031294) | 5.24149681 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.93978782 |
| 29 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.81762494 |
| 30 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.72610443 |
| 31 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.68981330 |
| 32 | positive regulation of tolerance induction (GO:0002645) | 4.65646054 |
| 33 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.62235468 |
| 34 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.62235468 |
| 35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.54051516 |
| 36 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.54051516 |
| 37 | modulation by symbiont of host immune response (GO:0052553) | 4.54051516 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 4.54051516 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 4.54051516 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.54051516 |
| 41 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.45412128 |
| 42 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.45412128 |
| 43 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.42511496 |
| 44 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.40853346 |
| 45 | activated T cell proliferation (GO:0050798) | 4.38096736 |
| 46 | macrophage activation involved in immune response (GO:0002281) | 4.35934424 |
| 47 | positive regulation of isotype switching (GO:0045830) | 4.34556822 |
| 48 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.24474187 |
| 49 | detection of other organism (GO:0098543) | 4.16220113 |
| 50 | regulation of regulatory T cell differentiation (GO:0045589) | 4.10341094 |
| 51 | tolerance induction (GO:0002507) | 4.09201373 |
| 52 | regulation of tolerance induction (GO:0002643) | 4.07998848 |
| 53 | neutrophil activation involved in immune response (GO:0002283) | 4.05241095 |
| 54 | regulation of isotype switching (GO:0045191) | 4.04154059 |
| 55 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.02449623 |
| 56 | sequestering of actin monomers (GO:0042989) | 4.00362496 |
| 57 | regulation of response to interferon-gamma (GO:0060330) | 3.99955317 |
| 58 | microglial cell activation (GO:0001774) | 3.99604120 |
| 59 | detection of bacterium (GO:0016045) | 3.97010729 |
| 60 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.96762907 |
| 61 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.93845641 |
| 62 | positive regulation of interleukin-2 production (GO:0032743) | 3.91897415 |
| 63 | positive regulation of B cell mediated immunity (GO:0002714) | 3.89441493 |
| 64 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.89441493 |
| 65 | negative regulation of interleukin-12 production (GO:0032695) | 3.87005931 |
| 66 | leukocyte cell-cell adhesion (GO:0007159) | 3.84959560 |
| 67 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.81983841 |
| 68 | positive regulation of humoral immune response (GO:0002922) | 3.81598504 |
| 69 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.81127210 |
| 70 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.79627050 |
| 71 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.77687852 |
| 72 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.76915575 |
| 73 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.75954501 |
| 74 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.75385171 |
| 75 | positive regulation of DNA recombination (GO:0045911) | 3.75151589 |
| 76 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.75025348 |
| 77 | negative regulation of T cell mediated immunity (GO:0002710) | 3.74755827 |
| 78 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.72040640 |
| 79 | B cell receptor signaling pathway (GO:0050853) | 3.71170393 |
| 80 | cellular extravasation (GO:0045123) | 3.67830926 |
| 81 | regulation of B cell differentiation (GO:0045577) | 3.67382818 |
| 82 | regulation of B cell mediated immunity (GO:0002712) | 3.66231516 |
| 83 | natural killer cell activation (GO:0030101) | 3.61469292 |
| 84 | detection of external biotic stimulus (GO:0098581) | 3.57808765 |
| 85 | respiratory burst (GO:0045730) | 3.57778499 |
| 86 | immunoglobulin mediated immune response (GO:0016064) | 3.55495833 |
| 87 | neutrophil activation (GO:0042119) | 3.54077714 |
| 88 | regulation of immunoglobulin production (GO:0002637) | 3.53238715 |
| 89 | regulation of cell killing (GO:0031341) | 3.50781340 |
| 90 | myeloid cell activation involved in immune response (GO:0002275) | 3.49020158 |
| 91 | positive regulation of immunoglobulin production (GO:0002639) | 3.48598920 |
| 92 | T cell differentiation (GO:0030217) | 3.47325718 |
| 93 | positive regulation of lamellipodium assembly (GO:0010592) | 3.44064894 |
| 94 | positive regulation of cell killing (GO:0031343) | 3.42845884 |
| 95 | dendritic cell chemotaxis (GO:0002407) | 3.42224335 |
| 96 | lymphocyte migration (GO:0072676) | 3.41650285 |
| 97 | detection of molecule of bacterial origin (GO:0032490) | 3.40198415 |
| 98 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.37845117 |
| 99 | mast cell activation (GO:0045576) | 3.37763219 |
| 100 | heterotypic cell-cell adhesion (GO:0034113) | 3.36749731 |
| 101 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.36054644 |
| 102 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.31093279 |
| 103 | positive regulation of B cell differentiation (GO:0045579) | 3.28753912 |
| 104 | T cell homeostasis (GO:0043029) | 3.28016269 |
| 105 | alpha-beta T cell activation (GO:0046631) | 3.27823137 |
| 106 | T cell activation (GO:0042110) | 3.27585420 |
| 107 | granulocyte activation (GO:0036230) | 3.26514103 |
| 108 | dendritic cell migration (GO:0036336) | 3.25790358 |
| 109 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.25579091 |
| 110 | macrophage activation (GO:0042116) | 3.24682874 |
| 111 | response to type I interferon (GO:0034340) | 3.23326408 |
| 112 | regulation of defense response to virus by virus (GO:0050690) | 3.21505447 |
| 113 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.20346446 |
| 114 | alpha-beta T cell differentiation (GO:0046632) | 3.19483841 |
| 115 | cytidine metabolic process (GO:0046087) | 3.16509072 |
| 116 | cytidine catabolic process (GO:0006216) | 3.16509072 |
| 117 | cytidine deamination (GO:0009972) | 3.16509072 |
| 118 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.16494500 |
| 119 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.15784506 |
| 120 | type I interferon signaling pathway (GO:0060337) | 3.15012210 |
| 121 | cellular response to type I interferon (GO:0071357) | 3.15012210 |
| 122 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.12838734 |
| 123 | detection of biotic stimulus (GO:0009595) | 3.10334385 |
| 124 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.09770018 |
| 125 | positive regulation of T cell activation (GO:0050870) | 3.09171968 |
| 126 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.08242139 |
| 127 | response to host immune response (GO:0052572) | 3.08242139 |
| 128 | positive regulation of granulocyte differentiation (GO:0030854) | 3.07347741 |
| 129 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.04050842 |
| 130 | positive regulation of immune response to tumor cell (GO:0002839) | 3.03991241 |
| 131 | regulation of immune response to tumor cell (GO:0002837) | 3.03991241 |
| 132 | regulation of response to tumor cell (GO:0002834) | 3.03991241 |
| 133 | positive regulation of response to tumor cell (GO:0002836) | 3.03991241 |
| 134 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.02664485 |
| 135 | cellular defense response (GO:0006968) | 3.02555163 |
| 136 | T cell proliferation (GO:0042098) | 3.01925681 |
| 137 | response to peptidoglycan (GO:0032494) | 3.00746779 |
| 138 | leukocyte degranulation (GO:0043299) | 2.98015036 |
| 139 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.97116467 |
| 140 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.96881104 |
| 141 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.95162644 |
| 142 | negative regulation of innate immune response (GO:0045824) | 2.94326241 |
| 143 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.90781316 |
| 144 | neutrophil mediated immunity (GO:0002446) | 2.88560917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.20418997 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.46403991 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.49631355 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.18664735 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.04391022 |
| 6 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.00332727 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.93766586 |
| 8 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.69257253 |
| 9 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.64745246 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 3.46221320 |
| 11 | * MYB_26560356_Chip-Seq_TH2_Human | 3.35286602 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.12862328 |
| 13 | * MAF_26560356_Chip-Seq_TH1_Human | 3.11144017 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.89409371 |
| 15 | * MYB_26560356_Chip-Seq_TH1_Human | 2.85197572 |
| 16 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.76899769 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.65349976 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.44080562 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.40689782 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.21925930 |
| 21 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.16219861 |
| 22 | MAF_26560356_Chip-Seq_TH2_Human | 2.14794961 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.12941172 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.08159105 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.05382654 |
| 26 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.98576205 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.98131327 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.97674044 |
| 29 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.95252323 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93181637 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.90689427 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90206310 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86883069 |
| 34 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.86572442 |
| 35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85989601 |
| 36 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.79341480 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.78115032 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.73731987 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73544383 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70291753 |
| 41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68072018 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.66010606 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.64410560 |
| 44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.64283769 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60688671 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54671790 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54324979 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51154783 |
| 49 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50158927 |
| 50 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.49003968 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.43903192 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.40795604 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40599756 |
| 54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38051964 |
| 55 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.37127447 |
| 56 | GATA3_26560356_Chip-Seq_TH2_Human | 1.33442068 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30808497 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28350229 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22949664 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20746387 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19702138 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19227673 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14855983 |
| 64 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10543771 |
| 65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09891857 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08996205 |
| 67 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07771632 |
| 68 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07722056 |
| 69 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07261058 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06350625 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05691456 |
| 72 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.04898643 |
| 73 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.03477324 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02187013 |
| 75 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00028756 |
| 76 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97588648 |
| 77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96555582 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94843263 |
| 79 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.93348458 |
| 80 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.93184529 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92222427 |
| 82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91860517 |
| 83 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.91107789 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90481808 |
| 85 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.90094305 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90034662 |
| 87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89331353 |
| 88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.85900977 |
| 89 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.85180236 |
| 90 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.84909777 |
| 91 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84354406 |
| 92 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.82958676 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82397214 |
| 94 | GATA1_22025678_ChIP-Seq_K562_Human | 0.81285384 |
| 95 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79183772 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78814102 |
| 97 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77095979 |
| 98 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76945615 |
| 99 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75872476 |
| 100 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.75182972 |
| 101 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.74759042 |
| 102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74455264 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.74212441 |
| 104 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.73962298 |
| 105 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.73585405 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73331277 |
| 107 | GATA3_26560356_Chip-Seq_TH1_Human | 0.71839982 |
| 108 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70924006 |
| 109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.70065268 |
| 110 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.69934975 |
| 111 | GATA1_19941826_ChIP-Seq_K562_Human | 0.66805178 |
| 112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66053671 |
| 113 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.65253823 |
| 114 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.63182817 |
| 115 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.61544525 |
| 116 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.60529614 |
| 117 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.59984449 |
| 118 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.59022428 |
| 119 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.58839570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 5.33831134 |
| 2 | MP0005671_abnormal_response_to | 5.06911923 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.81259406 |
| 4 | MP0000685_abnormal_immune_system | 3.78522220 |
| 5 | MP0001800_abnormal_humoral_immune | 3.44147031 |
| 6 | MP0005387_immune_system_phenotype | 3.26324189 |
| 7 | MP0001790_abnormal_immune_system | 3.26324189 |
| 8 | MP0002166_altered_tumor_susceptibility | 3.10174376 |
| 9 | * MP0002420_abnormal_adaptive_immunity | 2.97016563 |
| 10 | MP0006082_CNS_inflammation | 2.96849837 |
| 11 | * MP0001819_abnormal_immune_cell | 2.91880431 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.91880358 |
| 13 | MP0009785_altered_susceptibility_to | 2.91562764 |
| 14 | MP0002723_abnormal_immune_serum | 2.90061660 |
| 15 | MP0002398_abnormal_bone_marrow | 2.85702733 |
| 16 | MP0009333_abnormal_splenocyte_physiolog | 2.76954590 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.72422564 |
| 18 | MP0005025_abnormal_response_to | 2.61255107 |
| 19 | MP0003724_increased_susceptibility_to | 2.59805175 |
| 20 | MP0000716_abnormal_immune_system | 2.52459293 |
| 21 | MP0002006_tumorigenesis | 2.51388501 |
| 22 | MP0000703_abnormal_thymus_morphology | 2.43479752 |
| 23 | MP0002405_respiratory_system_inflammati | 2.40071636 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.33947166 |
| 25 | MP0002722_abnormal_immune_system | 2.30969203 |
| 26 | MP0000689_abnormal_spleen_morphology | 2.27436249 |
| 27 | MP0001873_stomach_inflammation | 2.26183536 |
| 28 | MP0003866_abnormal_defecation | 2.20824998 |
| 29 | MP0004947_skin_inflammation | 2.16224841 |
| 30 | MP0010155_abnormal_intestine_physiology | 2.13861808 |
| 31 | MP0002396_abnormal_hematopoietic_system | 2.12748819 |
| 32 | MP0002429_abnormal_blood_cell | 2.05277160 |
| 33 | MP0003436_decreased_susceptibility_to | 2.04128177 |
| 34 | MP0002933_joint_inflammation | 1.87839181 |
| 35 | MP0002419_abnormal_innate_immunity | 1.81627994 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.79251798 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.70184938 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.65307176 |
| 39 | MP0008260_abnormal_autophagy | 1.63384578 |
| 40 | MP0004510_myositis | 1.62211487 |
| 41 | MP0003303_peritoneal_inflammation | 1.62198733 |
| 42 | MP0000858_altered_metastatic_potential | 1.61519145 |
| 43 | MP0001853_heart_inflammation | 1.56463926 |
| 44 | MP0003690_abnormal_glial_cell | 1.54656708 |
| 45 | MP0004883_abnormal_blood_vessel | 1.53180689 |
| 46 | MP0003448_altered_tumor_morphology | 1.50705841 |
| 47 | MP0002277_abnormal_respiratory_mucosa | 1.35845630 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.29217428 |
| 49 | MP0003045_fibrosis | 1.26055672 |
| 50 | MP0008469_abnormal_protein_level | 1.25019003 |
| 51 | MP0005310_abnormal_salivary_gland | 1.13479192 |
| 52 | MP0001851_eye_inflammation | 1.12070929 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.09241253 |
| 54 | MP0005164_abnormal_response_to | 1.08257015 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.07808737 |
| 56 | MP0002009_preneoplasia | 1.06959153 |
| 57 | MP0002019_abnormal_tumor_incidence | 1.04690062 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.02617882 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.01249061 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.00972613 |
| 61 | MP0003183_abnormal_peptide_metabolism | 0.96797217 |
| 62 | MP0002132_abnormal_respiratory_system | 0.95960513 |
| 63 | MP0004381_abnormal_hair_follicle | 0.91981823 |
| 64 | MP0003075_altered_response_to | 0.91440746 |
| 65 | MP0005023_abnormal_wound_healing | 0.90689429 |
| 66 | MP0004130_abnormal_muscle_cell | 0.88051590 |
| 67 | MP0009763_increased_sensitivity_to | 0.87732317 |
| 68 | MP0002998_abnormal_bone_remodeling | 0.87094514 |
| 69 | MP0000490_abnormal_crypts_of | 0.86216383 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 0.73317819 |
| 71 | MP0001545_abnormal_hematopoietic_system | 0.73317819 |
| 72 | MP0003828_pulmonary_edema | 0.72634290 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.71621268 |
| 74 | MP0008961_abnormal_basal_metabolism | 0.71561742 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 0.70840876 |
| 76 | MP0010368_abnormal_lymphatic_system | 0.69130053 |
| 77 | MP0005390_skeleton_phenotype | 0.69077817 |
| 78 | MP0009764_decreased_sensitivity_to | 0.67382190 |
| 79 | MP0006054_spinal_hemorrhage | 0.66509949 |
| 80 | MP0001879_abnormal_lymphatic_vessel | 0.65903230 |
| 81 | MP0000609_abnormal_liver_physiology | 0.65164656 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.62776163 |
| 83 | MP0008004_abnormal_stomach_pH | 0.62596517 |
| 84 | MP0002254_reproductive_system_inflammat | 0.62325310 |
| 85 | MP0000249_abnormal_blood_vessel | 0.61278664 |
| 86 | MP0000477_abnormal_intestine_morphology | 0.59745609 |
| 87 | MP0001986_abnormal_taste_sensitivity | 0.58959405 |
| 88 | MP0001191_abnormal_skin_condition | 0.58125819 |
| 89 | MP0004484_altered_response_of | 0.57463016 |
| 90 | MP0000920_abnormal_myelination | 0.57010997 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.56898258 |
| 92 | MP0002822_catalepsy | 0.55924712 |
| 93 | MP0001348_abnormal_lacrimal_gland | 0.55437045 |
| 94 | MP0003091_abnormal_cell_migration | 0.54700628 |
| 95 | MP0005166_decreased_susceptibility_to | 0.54273839 |
| 96 | MP0008874_decreased_physiological_sensi | 0.53454044 |
| 97 | MP0005167_abnormal_blood-brain_barrier | 0.53234350 |
| 98 | MP0003077_abnormal_cell_cycle | 0.50756712 |
| 99 | MP0003795_abnormal_bone_structure | 0.50579350 |
| 100 | MP0000569_abnormal_digit_pigmentation | 0.49331777 |
| 101 | MP0005076_abnormal_cell_differentiation | 0.48873447 |
| 102 | MP0010234_abnormal_vibrissa_follicle | 0.48402289 |
| 103 | MP0009278_abnormal_bone_marrow | 0.47214347 |
| 104 | MP0000343_altered_response_to | 0.46531286 |
| 105 | MP0008873_increased_physiological_sensi | 0.46114810 |
| 106 | MP0000604_amyloidosis | 0.45855509 |
| 107 | MP0001243_abnormal_dermal_layer | 0.44815440 |
| 108 | MP0005381_digestive/alimentary_phenotyp | 0.44003954 |
| 109 | MP0003279_aneurysm | 0.43917006 |
| 110 | MP0009643_abnormal_urine_homeostasis | 0.43613368 |
| 111 | MP0005388_respiratory_system_phenotype | 0.42667155 |
| 112 | MP0002133_abnormal_respiratory_system | 0.42667155 |
| 113 | MP0003943_abnormal_hepatobiliary_system | 0.42399740 |
| 114 | MP0008057_abnormal_DNA_replication | 0.41998129 |
| 115 | MP0003252_abnormal_bile_duct | 0.41706315 |
| 116 | MP0003566_abnormal_cell_adhesion | 0.41546816 |
| 117 | MP0000598_abnormal_liver_morphology | 0.40339160 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.38975250 |
| 119 | MP0002168_other_aberrant_phenotype | 0.38248337 |
| 120 | MP0001663_abnormal_digestive_system | 0.38199085 |
| 121 | MP0001216_abnormal_epidermal_layer | 0.35303225 |
| 122 | MP0003191_abnormal_cellular_cholesterol | 0.34951114 |
| 123 | MP0005451_abnormal_body_composition | 0.33730964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.13656881 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.92015471 |
| 3 | Recurrent bronchitis (HP:0002837) | 5.77972697 |
| 4 | Abnormality of T cells (HP:0002843) | 5.42128129 |
| 5 | Nasal polyposis (HP:0100582) | 5.21333090 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.12343770 |
| 7 | Severe combined immunodeficiency (HP:0004430) | 5.03480701 |
| 8 | Chronic otitis media (HP:0000389) | 5.02629859 |
| 9 | Stomatitis (HP:0010280) | 4.92672262 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.87309609 |
| 11 | IgM deficiency (HP:0002850) | 4.85238229 |
| 12 | Abnormality of the nasal mucosa (HP:0000433) | 4.82921896 |
| 13 | Combined immunodeficiency (HP:0005387) | 4.82673102 |
| 14 | IgG deficiency (HP:0004315) | 4.64460985 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.24090043 |
| 16 | Recurrent fungal infections (HP:0002841) | 4.23081023 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 4.21218816 |
| 18 | Recurrent viral infections (HP:0004429) | 4.21070200 |
| 19 | Increased IgM level (HP:0003496) | 4.15667109 |
| 20 | Myositis (HP:0100614) | 4.07907849 |
| 21 | Lymphopenia (HP:0001888) | 3.92803467 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.92208216 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.92208216 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.89929073 |
| 25 | Abnormality of T cell physiology (HP:0011840) | 3.88095170 |
| 26 | Eczematoid dermatitis (HP:0000976) | 3.83199001 |
| 27 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.77839845 |
| 28 | Abnormality of the fingertips (HP:0001211) | 3.72009044 |
| 29 | Autoimmune hemolytic anemia (HP:0001890) | 3.70680623 |
| 30 | Chronic diarrhea (HP:0002028) | 3.58297127 |
| 31 | Pustule (HP:0200039) | 3.57112097 |
| 32 | Joint swelling (HP:0001386) | 3.54078928 |
| 33 | Agammaglobulinemia (HP:0004432) | 3.51128076 |
| 34 | Spontaneous hematomas (HP:0007420) | 3.44835178 |
| 35 | Abnormality of eosinophils (HP:0001879) | 3.43110578 |
| 36 | Meningitis (HP:0001287) | 3.37314737 |
| 37 | Recurrent sinusitis (HP:0011108) | 3.35764039 |
| 38 | Bronchitis (HP:0012387) | 3.33390114 |
| 39 | IgA deficiency (HP:0002720) | 3.33063213 |
| 40 | Thyroiditis (HP:0100646) | 3.24894567 |
| 41 | Vasculitis (HP:0002633) | 3.21244767 |
| 42 | Encephalitis (HP:0002383) | 3.17852578 |
| 43 | Abnormality of B cell number (HP:0010975) | 3.17479795 |
| 44 | B lymphocytopenia (HP:0010976) | 3.17479795 |
| 45 | Inflammation of the large intestine (HP:0002037) | 3.13077319 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 3.12002175 |
| 47 | Optic neuritis (HP:0100653) | 3.12002175 |
| 48 | Eosinophilia (HP:0001880) | 3.11596895 |
| 49 | Hemoptysis (HP:0002105) | 3.10617628 |
| 50 | Leukocytosis (HP:0001974) | 3.07825132 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 3.05747985 |
| 52 | Chronic sinusitis (HP:0011109) | 3.04442459 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 2.97216448 |
| 54 | Urticaria (HP:0001025) | 2.89889146 |
| 55 | Hypochromic anemia (HP:0001931) | 2.84705701 |
| 56 | Orchitis (HP:0100796) | 2.84372418 |
| 57 | Gastrointestinal infarctions (HP:0005244) | 2.84308948 |
| 58 | Recurrent abscess formation (HP:0002722) | 2.81893874 |
| 59 | Gingival bleeding (HP:0000225) | 2.78574402 |
| 60 | Granulocytopenia (HP:0001913) | 2.77260938 |
| 61 | Hypergammaglobulinemia (HP:0010702) | 2.75252530 |
| 62 | Pulmonary infiltrates (HP:0002113) | 2.74932388 |
| 63 | Papilloma (HP:0012740) | 2.73476197 |
| 64 | Verrucae (HP:0200043) | 2.73476197 |
| 65 | Hypochromic microcytic anemia (HP:0004840) | 2.64860140 |
| 66 | Lymphoma (HP:0002665) | 2.64113642 |
| 67 | Colitis (HP:0002583) | 2.63462480 |
| 68 | Recurrent otitis media (HP:0000403) | 2.56852252 |
| 69 | Basal cell carcinoma (HP:0002671) | 2.56180861 |
| 70 | Mediastinal lymphadenopathy (HP:0100721) | 2.54786228 |
| 71 | Gastrointestinal stroma tumor (HP:0100723) | 2.50504570 |
| 72 | Pulmonary embolism (HP:0002204) | 2.49987882 |
| 73 | Recurrent skin infections (HP:0001581) | 2.47239329 |
| 74 | Episodic fever (HP:0001954) | 2.46930622 |
| 75 | Arterial thrombosis (HP:0004420) | 2.46058436 |
| 76 | Keratoconjunctivitis sicca (HP:0001097) | 2.45980538 |
| 77 | Hemiplegia (HP:0002301) | 2.44582792 |
| 78 | Emphysema (HP:0002097) | 2.43537390 |
| 79 | Chronic obstructive pulmonary disease (HP:0006510) | 2.40808337 |
| 80 | Obstructive lung disease (HP:0006536) | 2.40808337 |
| 81 | Increased IgE level (HP:0003212) | 2.38507645 |
| 82 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.34308517 |
| 83 | Stomach cancer (HP:0012126) | 2.31584360 |
| 84 | Peritonitis (HP:0002586) | 2.28798671 |
| 85 | Chest pain (HP:0100749) | 2.27533408 |
| 86 | Hypoplasia of the thymus (HP:0000778) | 2.26933406 |
| 87 | Thrombocytosis (HP:0001894) | 2.26155175 |
| 88 | Abnormality of the pleura (HP:0002103) | 2.25861155 |
| 89 | Epistaxis (HP:0000421) | 2.22818809 |
| 90 | Hepatitis (HP:0012115) | 2.21581115 |
| 91 | Acute hepatic failure (HP:0006554) | 2.21423830 |
| 92 | Keratoconjunctivitis (HP:0001096) | 2.20373363 |
| 93 | Sepsis (HP:0100806) | 2.15503174 |
| 94 | Hypoproteinemia (HP:0003075) | 2.13923960 |
| 95 | Ureteral stenosis (HP:0000071) | 2.13288704 |
| 96 | Osteomyelitis (HP:0002754) | 2.12421127 |
| 97 | Hematochezia (HP:0002573) | 2.12403732 |
| 98 | Purpura (HP:0000979) | 2.11832791 |
| 99 | Petechiae (HP:0000967) | 2.09748523 |
| 100 | Abnormal platelet volume (HP:0011876) | 2.08915526 |
| 101 | Keratitis (HP:0000491) | 2.07506647 |
| 102 | Glomerulopathy (HP:0100820) | 2.07091368 |
| 103 | Prolonged bleeding time (HP:0003010) | 2.03457925 |
| 104 | Vertigo (HP:0002321) | 1.98397841 |
| 105 | Skin ulcer (HP:0200042) | 1.96833824 |
| 106 | Microcytic anemia (HP:0001935) | 1.96438945 |
| 107 | Bronchiectasis (HP:0002110) | 1.95114632 |
| 108 | Cheilitis (HP:0100825) | 1.93135881 |
| 109 | Ureteral obstruction (HP:0006000) | 1.93073014 |
| 110 | Abnormality of the prostate (HP:0008775) | 1.91990773 |
| 111 | Gingivitis (HP:0000230) | 1.91427164 |
| 112 | Abnormality of the peritoneum (HP:0002585) | 1.91267220 |
| 113 | Recurrent bacterial skin infections (HP:0005406) | 1.90458930 |
| 114 | Papilledema (HP:0001085) | 1.90235678 |
| 115 | Cellulitis (HP:0100658) | 1.88942343 |
| 116 | Gangrene (HP:0100758) | 1.87169671 |
| 117 | Acne (HP:0001061) | 1.86622388 |
| 118 | Increased density of long bones (HP:0006392) | 1.85687041 |
| 119 | Amaurosis fugax (HP:0100576) | 1.84422532 |
| 120 | Arthralgia (HP:0002829) | 1.78350124 |
| 121 | Restrictive lung disease (HP:0002091) | 1.75309333 |
| 122 | Anorexia (HP:0002039) | 1.75188028 |
| 123 | Abnormality of the endocardium (HP:0004306) | 1.74810588 |
| 124 | Skin rash (HP:0000988) | 1.74002277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.04568203 |
| 2 | MAP4K1 | 5.83222803 |
| 3 | RIPK4 | 3.85038935 |
| 4 | FGFR4 | 3.54139073 |
| 5 | ITK | 3.38665102 |
| 6 | JAK3 | 3.30300856 |
| 7 | ZAP70 | 2.93375534 |
| 8 | TYK2 | 2.80329510 |
| 9 | IKBKE | 2.80004942 |
| 10 | STK10 | 2.75307845 |
| 11 | KDR | 2.63570969 |
| 12 | JAK1 | 2.61362061 |
| 13 | FGFR3 | 2.20320424 |
| 14 | GRK6 | 2.12979321 |
| 15 | TAOK3 | 2.05242929 |
| 16 | LCK | 1.95317663 |
| 17 | MAP3K14 | 1.89090494 |
| 18 | TBK1 | 1.73710334 |
| 19 | FGR | 1.72795756 |
| 20 | NLK | 1.70468974 |
| 21 | CSK | 1.67948826 |
| 22 | TEC | 1.64914743 |
| 23 | PRPF4B | 1.60106443 |
| 24 | TESK2 | 1.55069149 |
| 25 | MAP3K11 | 1.48931858 |
| 26 | PRKCH | 1.44471771 |
| 27 | BTK | 1.41191477 |
| 28 | MST4 | 1.39427113 |
| 29 | PRKCQ | 1.38260012 |
| 30 | SYK | 1.37797981 |
| 31 | MAP3K10 | 1.36798170 |
| 32 | BLK | 1.35651785 |
| 33 | MAP3K13 | 1.33693163 |
| 34 | LRRK2 | 1.32796358 |
| 35 | KIT | 1.31884052 |
| 36 | TGFBR2 | 1.28644454 |
| 37 | HCK | 1.27176726 |
| 38 | MARK3 | 1.22090285 |
| 39 | MAP3K3 | 1.16917412 |
| 40 | SIK2 | 1.15436771 |
| 41 | PKN2 | 1.07905713 |
| 42 | CAMKK2 | 1.06959195 |
| 43 | PIK3CG | 1.01540020 |
| 44 | CLK1 | 0.99175169 |
| 45 | CAMKK1 | 0.96686210 |
| 46 | MAP3K12 | 0.95780846 |
| 47 | IKBKB | 0.92923530 |
| 48 | EEF2K | 0.90513846 |
| 49 | JAK2 | 0.90274904 |
| 50 | IRAK4 | 0.90114757 |
| 51 | FES | 0.89199054 |
| 52 | MAP3K1 | 0.87595064 |
| 53 | PIM1 | 0.84325740 |
| 54 | GRK7 | 0.83924076 |
| 55 | BMPR2 | 0.83664812 |
| 56 | LYN | 0.83444840 |
| 57 | YES1 | 0.81117299 |
| 58 | SIK3 | 0.80555600 |
| 59 | TTN | 0.75579069 |
| 60 | EPHB1 | 0.75366329 |
| 61 | TIE1 | 0.71652277 |
| 62 | CSF1R | 0.70947271 |
| 63 | RPS6KA4 | 0.69529889 |
| 64 | EPHA3 | 0.68168349 |
| 65 | TGFBR1 | 0.67368488 |
| 66 | PTK2B | 0.66684682 |
| 67 | TYRO3 | 0.64727571 |
| 68 | NME2 | 0.64391191 |
| 69 | TNK2 | 0.63645181 |
| 70 | MATK | 0.63542693 |
| 71 | MAP3K7 | 0.62264056 |
| 72 | TRIB3 | 0.61458079 |
| 73 | ERN1 | 0.54841770 |
| 74 | CHUK | 0.53924743 |
| 75 | PDK1 | 0.51843732 |
| 76 | MAPK11 | 0.50569555 |
| 77 | MAPK12 | 0.49330730 |
| 78 | MAPK7 | 0.49303901 |
| 79 | INSR | 0.48515828 |
| 80 | PDPK1 | 0.48231503 |
| 81 | IGF1R | 0.48147520 |
| 82 | CDK4 | 0.48053510 |
| 83 | MAP2K3 | 0.47723045 |
| 84 | KSR2 | 0.47326661 |
| 85 | MELK | 0.46809939 |
| 86 | FGFR1 | 0.46722167 |
| 87 | PDGFRB | 0.46487534 |
| 88 | PRKD2 | 0.45948771 |
| 89 | SGK3 | 0.43611058 |
| 90 | FYN | 0.42547036 |
| 91 | CDK12 | 0.42478806 |
| 92 | PTK6 | 0.42125545 |
| 93 | DMPK | 0.42045577 |
| 94 | STK11 | 0.41240815 |
| 95 | SGK2 | 0.40829498 |
| 96 | MAP2K6 | 0.39838520 |
| 97 | GRK5 | 0.39756297 |
| 98 | MAP3K5 | 0.37718724 |
| 99 | MARK2 | 0.37567686 |
| 100 | TAOK2 | 0.37540554 |
| 101 | DYRK1B | 0.36841483 |
| 102 | SIK1 | 0.35767469 |
| 103 | MAP3K2 | 0.35683408 |
| 104 | FLT3 | 0.35297488 |
| 105 | HIPK2 | 0.34318569 |
| 106 | CDC42BPA | 0.34295882 |
| 107 | ALK | 0.33994703 |
| 108 | MAPKAPK2 | 0.31278962 |
| 109 | FGFR2 | 0.30353508 |
| 110 | MYLK | 0.29879609 |
| 111 | STK4 | 0.27571001 |
| 112 | TAOK1 | 0.26449814 |
| 113 | RET | 0.25659687 |
| 114 | IRAK2 | 0.25633277 |
| 115 | CDK9 | 0.25599534 |
| 116 | TESK1 | 0.25464992 |
| 117 | CDK19 | 0.24908250 |
| 118 | PRKD1 | 0.24705352 |
| 119 | IRAK1 | 0.24566779 |
| 120 | STK38 | 0.23683523 |
| 121 | STK24 | 0.22799859 |
| 122 | EGFR | 0.20762365 |
| 123 | MAP3K8 | 0.20675399 |
| 124 | MAPK3 | 0.20229310 |
| 125 | ABL1 | 0.20091448 |
| 126 | PASK | 0.19160049 |
| 127 | MAPK4 | 0.18716398 |
| 128 | RAF1 | 0.17771535 |
| 129 | NUAK1 | 0.17705923 |
| 130 | RIPK1 | 0.17209490 |
| 131 | SRC | 0.17152040 |
| 132 | CDK6 | 0.16364615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.15311401 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.75652641 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.62767646 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.52090940 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.21693584 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.00005164 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.96651956 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.87321593 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.80614556 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.51562101 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.49122864 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 2.49019144 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.23146934 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.10110818 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.83529186 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.79132534 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.71282216 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58333611 |
| 19 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.55637309 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.49633564 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43781284 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40129379 |
| 23 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.37844582 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32765045 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.32255263 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24851787 |
| 27 | Hepatitis B_Homo sapiens_hsa05161 | 1.21371505 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20745417 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19498547 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12638556 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.12342886 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.09488901 |
| 33 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08046276 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.06017955 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.05281453 |
| 36 | HTLV-I infection_Homo sapiens_hsa05166 | 1.05108663 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04450430 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04027274 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.03721674 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 1.03614830 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02332474 |
| 42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.97642914 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.94774161 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94621406 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 0.94005495 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89485891 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83658755 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.83019239 |
| 49 | Ribosome_Homo sapiens_hsa03010 | 0.78907598 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78871368 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77582269 |
| 52 | Colorectal cancer_Homo sapiens_hsa05210 | 0.77260517 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75494372 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67066410 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 0.66561123 |
| 56 | Tuberculosis_Homo sapiens_hsa05152 | 0.66165356 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63418435 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63015612 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58426986 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57255438 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56390729 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56186489 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55229811 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54327208 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.54141856 |
| 66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54136997 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53913405 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53074628 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.52797404 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52128552 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.50761633 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47544332 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46943463 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45768239 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45293319 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45240043 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45209805 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44616046 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44245159 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44173357 |
| 81 | Spliceosome_Homo sapiens_hsa03040 | 0.42488793 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.37676358 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36449557 |
| 84 | Adherens junction_Homo sapiens_hsa04520 | 0.35579213 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34519741 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34232197 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.33454100 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.33072559 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.31343030 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.31316659 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.31283852 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30493730 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29893484 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29241012 |
| 95 | Base excision repair_Homo sapiens_hsa03410 | 0.28782571 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.27849197 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27071177 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.26380198 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.25483211 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24655120 |
| 101 | Long-term potentiation_Homo sapiens_hsa04720 | 0.24498425 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24127346 |
| 103 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.22828132 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.22643973 |
| 105 | RNA degradation_Homo sapiens_hsa03018 | 0.22610918 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21668148 |
| 107 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.20099530 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.19832303 |
| 109 | ABC transporters_Homo sapiens_hsa02010 | 0.19147091 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18177255 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.17958008 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.17736579 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15647678 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.14529563 |
| 115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.12422876 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.12052731 |
| 117 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.11958509 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.11584996 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.08895063 |

